Carolyn Sangokoya

Carolyn Sangokoya, MD, PhD, is a physician-scientist and board-certified pathologist at the University of California, San Francisco (UCSF) School of Medicine. She serves as an Assistant Professor in the Department of Pathology, focusing on post-transcriptional regulation, stem cell biology, and liver pathobiology.

• Stanford University (AB in Human Biology, Molecular Genetics concentration)
• Duke University (MD/PhD in Medical Scientist Training Program)
• UCSF (Anatomic & Gastrointestinal Pathology fellowships, postdoctoral training)

Her research integrates genome engineering and single-cell cytometry to decode molecular networks in cell fate reprogramming. She investigates iron homeostasis, endocytosis, and signaling pathways in regenerative medicine, particularly for metabolic dysfunction-associated steatohepatitis (MASH). Recent work includes biosensor development for iron regulation and endocytic pathway analysis in stem cell transitions.

Key publication themes include:

• Iron regulatory protein dynamics (2025)
• Single-cell endocytosis quantification (2022)
• MicroRNA control of pluripotency via PFN2 inhibition (2020)
• Stress-response microRNAs in liver and hematological diseases (2013-2010)

Major awards span career development grants (NIH K08, Burroughs Wellcome), leadership recognitions (ISSCR Public Service Award), and innovative research honors (Gordon Research Conferences Travel & Session Chair). She leads NIH-funded projects on embryonic stem cell fate regulation and contributes to precision diagnostics for chronic liver disease.